Article
Antisense therapy in a new rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment
2021-01-31
Abstract excerpt
Alexander disease (AxD) is a devastating leukodystrophy caused by gain of function mutations in GFAP , and the only available treatments are supportive. Recent advances in antisense oligonucleotide (ASO) therapy have demonstrated that transcript targeting can be a successful strategy for human neurodegenerative diseases amenable to this approach. We have previously used mouse models of AxD to show that Gfap -tar...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 838b1588-9d3c-5bb7-9a6c-e1af6999a009
- DOI
- 10.1101/2021.01.29.428244
